Study Explores Factors Leading to Unnecessary Lower-Spine MRIs
A study investigated the factors that add to unnecessary lumbar spine MRIs in uncomplicated low-back pain.
Pain Management
Overdose, Relapse After Buprenorphine Discontinuation High
The longer patients continue with buprenorphine treatment, the lower their risk of adverse outcomes.
Evidence Supports Use of High-Dose Aspirin for Migraine
High-dose aspirin safe, effective for acute migraine; low-dose aspirin can prevent recurrent attacks.
Addressing Two Public Health Epidemics: Suicide and Opioid Addiction
Traditionally, suicide and overdose prevention in opioid use disorder involve stratifying risk based on certain demographic and clinical factors.
Advance Practice Providers Still Encounter Barriers to Prescribing Buprenorphine for Opioid Use Disorder
Researchers sought to describe the practice patterns of NPs and PAs, understand the barriers these providers face in providing buprenorphine treatment, and compare them with their physician counterparts and across varying levels of practice autonomy.
CBD: A Primer for the PCP
Clinicians are routinely asked by their patients if CBD products are safe and effective, but research is lagging behind public acceptance.
Type of Initial Provider Consulted for New-Onset LBP May Influence Opioid Use
Patients with new-onset low back pain who initially consulted a chiropractor or physical therapist vs a primary care physician were found to have reduced risk for long-term opioid use.
Early Access to Chiropractors, PTs Tied to Decreased Long-Term Opioid Use
Odds of short- or long-term opioid use higher for initial visits with physicians for low back pain.
Impact of Tightening Opioid Regulations in Patients With Chronic Pain
Patients on long-term opioid treatment for chronic pain reported experiencing negative physical side effects, emotional distress, and degraded relationships with their primary care provider.
Clinical Guideline on Injectable Opioid Agonist Treatment for Severe Opioid Use Disorder
The Canadian Research Initiative in Substance Misuse National Injectable Opioid Agonist Treatment Steering Committee has released a new guideline on the use of injectable opioid agonist treatment for opioid use disorder.
Next post in Pain Management Information Center
